Iron Gate Global Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,980	Closed	-$207K	–	103
2022 Q4	$207K	Sell	21,980 -2,000	-8%	-$8.93K	0.06%	80
2022 Q3	$65K	Hold	23,980	–	–	0.02%	84
2022 Q2	$69K	Hold	23,980	–	–	0.02%	87
2022 Q1	$72K	Hold	23,980	–	–	0.02%	101
2021 Q4	$110K	Hold	23,980	–	–	0.03%	117
2021 Q3	$150K	Hold	23,980	–	–	0.04%	111
2021 Q2	$145K	Buy	+23,980	New	+$142K	0.04%	106
2021 Q1	–	Sell	-19,030	Closed	-$107K	–	107
2020 Q4	$107K	Hold	19,030	–	–	0.04%	90
2020 Q3	$111K	Buy	19,030 +800	+4%	+$5.51K	0.05%	95
2020 Q2	$131K	Sell	18,230 -7,640	-30%	-$50.7K	0.06%	83
2020 Q1	$121K	Hold	25,870	–	–	0.08%	53
2019 Q4	$207K	Hold	25,870	–	–	0.12%	63
2019 Q3	$178K	Hold	25,870	–	–	0.11%	68
2019 Q2	$215K	Hold	25,870	–	–	0.14%	60
2019 Q1	$257K	Hold	25,870	–	–	0.18%	63
2018 Q4	$198K	Sell	25,870 -3,150	-11%	-$37.7K	0.15%	57
2018 Q3	$318K	Buy	29,020 +16,772	+137%	+$200K	0.21%	43
2018 Q2	$116K	Buy	12,248 +200	+2%	+$1.33K	0.09%	59
2018 Q1	$53K	Buy	12,048 +1,270	+12%	+$7.03K	0.04%	53
2017 Q4	$44K	Buy	+10,778	New	+$31.3K	0.04%	49